Sort   by:  
 Page size 
UnknownHealth-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial.
Not available
S-EPMC6366953 | biostudies-literature
UnknownDistinct domains of the AVRPM3<sup>A2/F2</sup> avirulence protein from wheat powdery mildew are involved in immune receptor recognition and putative effector function.
Not available
S-EPMC6175116 | biostudies-literature
UnknownThe AvrPm3-Pm3 effector-NLR interactions control both race-specific resistance and host-specificity of cereal mildews on wheat.
Not available
S-EPMC6533294 | biostudies-literature
UnknownPopulation genomics and molecular epidemiology of wheat powdery mildew in Europe.
Not available
S-EPMC12047814 | biostudies-literature
UnknownEXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.
Not available
S-EPMC10105400 | biostudies-literature
UnknownAnalysis of shared heritability in common disorders of the brain.
Not available
S-EPMC6097237 | biostudies-literature
UnknownTime-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Not available
S-EPMC12214479 | biostudies-literature
UnknownExploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Not available
S-EPMC12170883 | biostudies-literature
UnknownHoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
Not available
S-EPMC8711238 | biostudies-literature
UnknownA Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Not available
S-EPMC8518716 | biostudies-literature
Sort   by:  
 Page size